95182-37-9 Usage
Description
1-(4-aminophenyl)-3-methylimidazolidin-2-one, also known as meclofenoxate, is a chemical compound that functions as a nootropic agent, which is believed to enhance cognitive function. As a derivative of the neurotransmitter GABA, meclofenoxate has been demonstrated to improve attention and memory in studies. It also possesses neuroprotective properties, making it a potential candidate for the treatment of neurodegenerative diseases. Furthermore, its antioxidant effects contribute to overall brain health. Meclofenoxate is commonly incorporated into dietary supplements and is deemed safe for human consumption, although it may cause mild side effects in some individuals.
Uses
Used in Pharmaceutical Industry:
1-(4-aminophenyl)-3-methylimidazolidin-2-one is used as a nootropic agent for enhancing cognitive function, particularly attention and memory. Its neuroprotective properties make it a potential treatment for neurodegenerative diseases, while its antioxidant effects contribute to overall brain health.
Used in Dietary Supplements:
1-(4-aminophenyl)-3-methylimidazolidin-2-one is used as an ingredient in dietary supplements to support cognitive enhancement and brain health. Its inclusion in these supplements aims to provide users with improved attention, memory, and protection against neurodegenerative conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 95182-37-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,1,8 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 95182-37:
(7*9)+(6*5)+(5*1)+(4*8)+(3*2)+(2*3)+(1*7)=149
149 % 10 = 9
So 95182-37-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N3O/c1-12-6-7-13(10(12)14)9-4-2-8(11)3-5-9/h2-5H,6-7,11H2,1H3
95182-37-9Relevant articles and documents
NEW COMPOUNDS
-
Page/Page column 21, (2008/12/06)
The present invention encompassescompounds of general formula (1) wherein R1 to R4 , X and n are defined as in claim 1, which are suitable for the treatment of ailments characterised byexcessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
